Top Banner
Sjogren’s Syndrome: Comp arison of Assessments wi th Quantitative Salivary Gland Scintigraphy and C ontrast Sialography J Nucl Med 2000; 41: 257-262
35

Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

Jan 15, 2016

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography

J Nucl Med 2000; 41: 257-262

Page 2: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

Sjogren’s Syndrome

• Autoimmune disease– Affecting salivary and lacrimal glands– Xerostomia (the most common oral symptom).

• The complaints of patients do not necessarily reflect the severity of their salivary gland disease.

Page 3: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

Sjogren’s syndrome

• Contrast sialography– Gold standard in the diagnosis of the syndrome– Invasive method (disadvantages and complications)

• Salivary gland scintigraphy with 99mTc-sodium pertechnetate– Evaluate salivary gland function in xerostomic pateint

s– Easy and noninvasive method (bilateral parotid and s

ubmandibular glands)

Page 4: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• No standard method for assessing Sjorgren’s syndrome has been established

• No report has deal with the relationships between quantitative scintigraphic parameters and sialographic findings

Page 5: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• In this study – Comparing quantitative parameters of salivary

gland scintigraphy and sialographic findings in Sjogren’s syndrome.

– Determining useful scintigaphic parameters for evaluation of salivary gland disease and calculated an equation to correlate the sialographic stage with the scintigraphic parameters.

Page 6: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

MATERIALS AND METHODS

Page 7: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Patients– 116 consecutive patients (105 woman, 11 men; age r

ange, 18-77 y; mean age, 54 y) who had xerostomia and were clinically suspected of having Sjogren’s syndrome.

– Sjogren’s syndrome was diagnosed in 50 of the 116 patients (contrast sialography as gold standard), and confirmed by complete P.E., laboratory testing, labial salivary gland biopsy (all showed histopathological changes of grade 1 or greater).

Page 8: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Imaging Examination– Dynamic salivary scintigraphy

• Performed after intravenous injection of 370 MBq 9

9mTc-sodium pertechnetate• Γ camera and analysis system

Page 9: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

FIGURE 1. Schematic presentation of time-activity curve in salivary gland scintigraphy. This represents normal pattern.

lemon juice

Page 10: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

TABLE 1. Definition of Functional Parameters in Salivary Gland Scintigraphy

Page 11: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• UR and MA: quantity of accumulation

• MS: quantity of secretion.

• Tmax: velocity of accumulation and spontaneous secretion.

• Tmin: velocity of secretion after stimulation

Page 12: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Imaging examination– Contrast sialography

• A catheter was used to inject a 0.5 to 0.7 ml dose of iohexol into the Stensen’s duct in patients.

Page 13: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Contrast sialograms– Rubin and Holt classification

Stage Contrast Material Collection ( in diameter )

0 ( normal ) No contrast material collection

1 ( punctate ) < 1 mm

2 ( globular ) 1-2 mm

3 ( cavitary ) >2 mm

4 ( destructive ) Complete destruction of the gland parenchyma

Page 14: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

RESULTS

Page 15: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

TABLE 2. Comparison of Scintigraphic Parameters in Healthy Volunteers and Patients with Sjogren’s syndrome

Page 16: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

TABLE 3. Correlation of Scintigraphic Parameters and Sialographic Staging in Patients with Sjogren’s syndrome

Page 17: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Regression analysis– In the submandibular gland, decrease of the tr

acer accumulation highly correlated with the sialographic staging (UR: r= -0.528, P<0.0001; MA: r= -0.554, P<0.0001)

– in the parotid gland, dcrease of the tracer secretion highly correlated with the sialographic staging (MS: r= -0.570, P<0.0001)

Page 18: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Sialographic stage = 3.243 - 0.337× (submandibular UR) – 0.026 × (parotid MS)

Page 19: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

FIGURE 2. Images of 31-y-old woman without Sjogren’s syndrome (sialographic stage 0)

Page 20: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.
Page 21: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

FIGURE 3. Images of 56-y-old woman (patient 2) with Sjigren’s syndrome (sialographic stage 2).

Page 22: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.
Page 23: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

FIGURE 4. Images of 54-y-old woman (patient 3) with Sjogren’s syndrome (sialographic stage 4).

Page 24: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.
Page 25: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

DISCUSSION

Page 26: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Contrast sialography– Gold standard in the diagnosis of the syndrom

e– Invasive method– Potential complications

• Failure of the cannulation procedure, duct trauma, painful overfilling of the gland, infection, and contrast material reactions.

Page 27: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Salivary gland scintigraphy with 99mTc-sodium pertechnetate– Evaluate salivary gland function in xerostomic pateint

s– Easy and noninvasive method (bilateral parotid and s

ubmandibular glands)– No standard method for assessing Sjorgren’s syndro

me has been established– No report has deal with the relationships between qua

ntitative scintigraphic parameters and sialographic findings

Page 28: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• UR, Tmax, Tmin, MA, and MS as quantitative parameters of salivary gland function.

• UR and MA: quantity of accummulation

• MS: quantity of secretion.

• Tmax: velocity of accumulation and spontaneous secretion.

• Tmin: velocity of secretion after stimulation.

Page 29: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• UR and MA of the submandibular gland and the MS of the parotid gland are highly correlated with the sialographic staging– Decreased accumulation in the submandibula

r gland and decreased secretion in the parotid gland are highly sensitive indicators of salivary gland disease in Sjogren’s syndrome

– Previous report (Umehara et al., 1999)

Page 30: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Why?– Parenchymal volumes, spontaneous secretion,

compositions of serous and mucous glands.– Further study is needed to clarify the different

functional change between the parotid and submandibular glands in Sjogren’s syndrome

– The function of the submandibular gland was more affected than that of the parotid gland. (S

ugihara et al., 1988 and Hakansson et al., 1994 )

Page 31: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Controversy remains as to which parameter is better for assessing salivary gland disease.( Hausler

et al., 1977, Arrago., 1987, Hakansson., 1994, Bohuslavizki., 1995)

• The study indicated that decreased accumulation in the submandibular gland and decreased secretion in the parotid gland are highly sensitive indicators of salivary gland disease in Sjogren’s syndrome

Page 32: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Sjogren’s syndrome was statistically significantly correlated with scintigraphic parameters – By means of stepwise regression analysis (sia

lographic stage versus UR of the submandibular gland and MS of the parotid gland)

Page 33: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

CONCLUSION

Page 34: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

• Sjogern’s syndrome – Salivary gland scintigraphy

• Easy and noninvasive method• Quantitative analysis : decreased accumulation in t

he submandibular gland and decreased secretion in the parotid gland are highly sensitive parameters

• Sialographic stage was correlated with these scintigraphic parameters

Page 35: Sjogren’s Syndrome: Comparison of Assessments with Quantitative Salivary Gland Scintigraphy and Contrast Sialography J Nucl Med 2000; 41: 257-262.

THANK YOU